These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2957388)

  • 21. Chronic-relapsing experimental autoimmune encephalomyelitis. Myelin basic protein induces suppression of blastogenesis during remissions but not during exacerbations.
    Lyman WD; Brosnan CF; Raine CS
    J Neuroimmunol; 1985; 7(5-6):345-53. PubMed ID: 2579093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic relapsing experimental allergic encephalomyelitis. Studies in vascular permeability changes.
    Kristensson K; Wiśniewski HM
    Acta Neuropathol; 1977 Aug; 39(3):189-94. PubMed ID: 906801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo 4.0-T magnetic resonance investigation of spinal cord inflammation, demyelination, and axonal damage in chronic-progressive experimental allergic encephalomyelitis.
    Cook LL; Foster PJ; Mitchell JR; Karlik SJ
    J Magn Reson Imaging; 2004 Oct; 20(4):563-71. PubMed ID: 15390226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progressive demyelination and reparative phenomena in chronic experimental allergic encephalomyelitis.
    Snyder DH; Valsamis MP; Stone SH; Raine CS
    J Neuropathol Exp Neurol; 1975 May; 34(3):209-21. PubMed ID: 1141960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of myelin antigens in murine relapsing experimental allergic encephalomyelitis.
    Lublin FD
    J Clin Lab Immunol; 1984 Apr; 13(4):179-82. PubMed ID: 6204053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evoked potentials (EPs) in experimental allergic encephalomyelitis: a study of EP modifications during the course of a controlled disease.
    Onofrj M; Gambi D; Bazzano S; Colamartino P; Fulgente T; Malatesta G; Ferracci F
    Electromyogr Clin Neurophysiol; 1992 Mar; 32(3):125-35. PubMed ID: 1555527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunomorphological characteristics of experimental allergic encephalomyelitis induced by an encephalitogenic polypeptide].
    Zhitnukhin IuL; Khizhniak MG
    Biull Eksp Biol Med; 1987 Mar; 103(3):343-6. PubMed ID: 2435338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration.
    van Strien ME; de Vries HE; Chrobok NL; Bol JGJM; Breve JJP; van der Pol SMP; Kooij G; van Buul JD; Karpuj M; Steinman L; Wilhelmus MM; Sestito C; Drukarch B; Van Dam AM
    Brain Behav Immun; 2015 Nov; 50():141-154. PubMed ID: 26133787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic relapsing EAE. Time course of neurological symptoms and pathology.
    Lassmann H; Wisniewski HM
    Acta Neuropathol; 1978 Aug; 43(1-2):35-42. PubMed ID: 676685
    [No Abstract]   [Full Text] [Related]  

  • 30. Active inflammation increases the heterogeneity of MRI texture in mice with relapsing experimental allergic encephalomyelitis.
    Zhang Y; Wells J; Buist R; Peeling J; Yong VW; Mitchell JR
    Magn Reson Imaging; 2014 Feb; 32(2):168-74. PubMed ID: 24246391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Similarities between the Forssman carotid syndrome and experimental allergic encephalomyelitis.
    Tsukada N; Ansar Ahmed S; Behan WM; Behan PO
    Acta Neuropathol; 1986; 69(3-4):234-43. PubMed ID: 3515833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization by acid alpha-naphthyl acetate esterase staining of the spinal cord cellular infiltrate in the acute and relapse phases of chronic relapsing experimental allergic encephalomyelitis.
    Suckling AJ; Kirby JA; Rumsby MG
    Prog Brain Res; 1983; 59():317-22. PubMed ID: 6198682
    [No Abstract]   [Full Text] [Related]  

  • 33. A new pattern of spinal-cord demyelination in guinea pigs with acute experimental allergic encephalomyelitis mimicking multiple sclerosis.
    Colover J
    Br J Exp Pathol; 1980 Aug; 61(4):390-400. PubMed ID: 7426390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathology-guided MR analysis of acute and chronic experimental allergic encephalomyelitis spinal cord lesions at 1.5T.
    Cook LL; Foster PJ; Karlik SJ
    J Magn Reson Imaging; 2005 Aug; 22(2):180-8. PubMed ID: 16028251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The localisation of fibrin, fibronectin and class II major histocompatibility complex antigen in the spinal cord in chronic relapsing experimental allergic encephalomyelitis.
    Butter C; Healey DG; Agha N; Wilcox CE; Antoniou AV; Turk JL
    J Neuroimmunol; 1989 Mar; 22(1):11-7. PubMed ID: 2465310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fenestrated CNS blood vessels in chronic experimental allergic encephalomyelitis.
    Synder DH; Hirano A; Raine CS
    Brain Res; 1975 Dec; 100(3):645-9. PubMed ID: 1192197
    [No Abstract]   [Full Text] [Related]  

  • 37. Delayed, relapsing experimental allergic encephalomyelitis in mice.
    Lublin FD; Maurer PH; Berry RG; Tippett D
    J Immunol; 1981 Mar; 126(3):819-22. PubMed ID: 7462632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pathological findings of axonal injury in a rat model of experimental allergic encephalomyelitis].
    Wang Y; Lv T; Liu X; Fang M; Liang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Apr; 32(4):482-6. PubMed ID: 22543126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteolytic enzymes in ordinary, hyperacute, monocytic and passive transfer forms of experimental allergic encephalomyelitis.
    Marks N; Grynbaum A; Levine S
    Brain Res; 1977 Mar; 123(1):147-57. PubMed ID: 843913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of pregnancy on experimental allergic encephalomyelitis in guinea pigs and rats.
    Keith AB
    J Neurol Sci; 1978 Oct; 38(3):317-26. PubMed ID: 569689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.